Question31 Mar 2020 20:33
Before some may slate me, I am a holder here and sincerely want Faron to do well. With the drugs they have in development and excellent ceo I have faith all of us will see a decent return (if not already) but turning to T. If we have patents, fast track status, why isn’t T taking off considering and as we all know CV causes ARDS? we have a drug that can help with that but the only coverage I see is from proactive investor.
The ceo could be waiting for the right moment but partner discussions are still ongoing as noted by the ceo. I guess like others I’m impatient and that’s something I have to deal with. GLA, keep the faith and take care.